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a  b  s  t  r  a  c  t
The  molecular  basis  of  cellular  memory  is a fascinating  topic  that  progressed  with great  strides  during
the  last  few  decades.  In  the  case  of cells  of  the  immune  system,  cellular  memory  likely  extends  beyond
cell  fate determination  mechanisms,  since  immunity  can  tailor  its responses  to a potentially  hostile  envi-
ronment  that  is  a priori  variable  if not  unpredictable.  One  particularly  versatile  innate  immune  system
cell  type  is  the  macrophage.  These  phagocytes  occur  in  all organs  and  tissues  as  resident  cells  or  as  differ-
entiation  products  of  recruited  circulating  blood  monocytes.  They  come  in  many  ﬂavours  determined  by
the tissue  of residence  and by external  factors  such  as microbes.  Recently,  macrophage  epigenome  proﬁl-
ing has  revealed  thousands  of chromosomal  loci  that  are  differentially  active  in  macrophages,  revealing
chromosome  elements  that drive  macrophage  gene  expression.  The  most  dynamic  epigenomic  mark  is
nucleosomal  histone  acetylation.  This  mark is found  at gene  promoters  and  enhancers  and  correlates  very
well  with  gene  expression  changes.  A  second  mark  is H3K4me3,  which  sharply  decorates  the  promoters
of  most  protein  coding  genes  that  are (potentially)  expressed.  H3K4me3  at promoters  is  surrounded  by
its  precursor  H3K4me1.  However,  most  often  H3K4me1  occurs  without  H3K4me3  at  enhancers  where
it appears  together  with  histone  acetylation,  but  can persist  long  after  acetylation  decreased.  Hence,
the  biochemical  signal  H3K4me1  embodies  appears  to be a key  to the plasticity  of macrophage  gene
expression  potential.
©  2016  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license
(http://creativecommons.org/licenses/by/4.0/).
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. Introduction
The development of an adult organism from a zygote remains
ne of the most wondrous biological phenomena. Over a century
f scientiﬁc research indicates that the molecular basis of this
xtraordinary feat is coded by the respective organism’s DNA
enome. The intricate ballet of cellular migrations that occurs dur-
ng early embryogenesis produces functional cells in all organs
ithin one body with very high ﬁdelity. This implies that very high
evels of determinism are ultimately encoded in the DNA sequence.
learly, the genome harbours a detailed blueprint to make and
aintain a body. The question we will address here is how chro-
osomes store information such as ‘memories’, with a focus on
acrophages.
. From chromatin to chromosome domains
How does a differentiating monocyte acquire and maintain its
acrophage (Mf) identity at the hand of a DNA code common to
very other cell? Part of the answer to this question lies in the
6 human chromosomes and their biochemical milieu, namely
hromatin. The diploid human genome contains ∼6 109 bp. This
epresents about 2 m of DNA, which ﬁt in a cell nucleus that is
0–20 m in diameter. Except during cell division, when chro-
osomal DNA is highly compacted to enable sister chromatid
egregation to the daughter cells, each chromosome occupies a dis-
inct territory within the nucleoplasm and intermingles little with
ther chromosomes [1,2].
Chromosomal DNA is packaged in arrays of nucleosomes. These
re discs, ∼11 nm in diameter and 5.5 nm in height, that consist of
n octamer of histone proteins (H32-H42)(H2A-H2B)2 and ∼147 bp
f DNA [3]. The length of the linker DNA between any two nucle-
somes varies from less than 10 to over 90 bp, with dominant
ucleosome repeat lengths of 190–200 bp in human blood cells [4].
n fact, the nucleotide composition of DNA can help to rotationally
osition DNA on the nucleosome surface through phased TA, TT,
A and GC dinucleotides positioned every 10/11 bp or multiples
hereof, suggesting that the DNA strands’ sequences themselves
an inﬂuence nucleosomal DNA packaging [5–7]. Because nucleo-
omes can stack in various solenoidal structures, some of which are
avoured by short or long linker lengths [8], arrays of nucleosome
an form higher order structures that are often modelled as one- or
wo-start solenoids of polynucleosomal ﬁbres [9] that are ∼30 nm
ide [10].
Some 20,000 protein coding genes are distributed along the
ength of the human chromosomes. Every gene has one or more
romoters from which transcription of mRNAs by RNA polymerase
I (RNAPII) can start [11]. Furthermore, distal elements called
enhancers’ modulate the activity of the promoters [12,13]. Differ-
nt cell types activate gene expression differentially by utilizing
ifferent parts of the genome’s regulatory repertoire of cis-acting
lements. The mechanisms underlying the differential use of the
enomes’ regulatory elements involve physical changes in chro-
atin that promote or inhibit gene expression [14–16].
From a regulatory perspective, the genome is partitioned in sev-
ral thousand independently functioning ‘topologically associated
omains’ (TADs). These have been deﬁned using formaldehyde-
xed cellular chromosome restriction cleavage followed by
igation, allowing interacting chromosome segments to be detected
s ligation products that are amenable to next-generation DNA
equencing [17]. TADs are relatively invariant, even across mam-
alian orders such as primates and rodents [18], although it is
ossible that TADs vary in conformation during ontogeny [19]. An
arly study reported ∼2000 TADs ranging in size from 80 kb to
0 Mb  [18]. Considering that DNA sequences located within one Immunology 28 (2016) 359–367
TAD are crosslinked signiﬁcantly more often than segments located
in adjacent TADs, the current model is that genes within one TAD
can be inﬂuenced by cis-acting regulatory elements within that TAD
through DNA looping, while genes outside the TAD are much less
likely to be contacted [20]. Much research indicates that a protein
ring consisting of cohesin works together with a very tight DNA
binding protein called CTCF to establish TAD boundaries, presum-
ably by forming the basis of stable chromatin loops [21–24]. It is
thought that they act as ‘boundaries’ because they can interrupt
or prevent enhancer-promoter contacts [25]. Intriguingly, inter-
chromosomal clustering of a select number of TADs marked by the
repressive H3K27me3 histone modiﬁcation has been documented
recently in embryonic stem cells [26–28]. Furthermore, some TADs
correspond to nuclear lamin associated domains [29]. The bio-
physical properties of topologically associated chromatin domains
remain to be elucidated.
3. Epigenetic mechanisms
Currently, epigenetic mechanisms encompass post-
transcriptional molecular systems, such as production of
microRNAs, which can regulate mRNAs in trans through base
pairing, leading to translation inhibition or mRNA degradation
[30]. However, most epigenetic mechanisms described to date
implicate protein-DNA interactions that affect gene expression at
the level of mRNA synthesis, either by chemically modifying DNA
bases, as is the case for 5-methyl cytosine, or by recruiting protein
complexes involved in nucleosome modiﬁcation and remodelling
that modulate chromatin structure to promote or inhibit tran-
scription initiation or elongation. The concept of epigenetics as
formulated by Conrad Waddington in 1942 for ontogenesis [31],
by Mary Lyon for X chromosome inactivation in female eutherians
[32] and by Arthur Riggs [33] and Robin Holliday [34] for 5-methyl
cytosine suggests that epigenetic mechanisms are involved in
establishing heritable chromatin states [35]. Hence, epigenetics
could be said to deal with mechanisms to establish durable
decisions, while gene control may also describe more punctual
ﬂuctuations in transcription levels. Still, the distinction between
transcription control and epigenetic control of gene expression
is probably a semantic one when considering the question at the
molecular level since nucleosomes are involved in both cases
[36]. DNA-bound histones in the form of nucleosomes are ideally
suited to perform molecular memory-related tasks because their
residence time on DNA can be of the order of many hours [37–39].
3.1. Chromatin remodelling
Nucleosomal histones can recruit proteins that harbour histone
binding domains [40–42]. When those interactions are promoted
or disrupted by post-translational modiﬁcation of histone residues
such as lysines and arginines the function of the underlying DNA
can change [43–48]. The protein domains that recognise modiﬁed
histones are commonly called ‘readers’ of the histone modiﬁ-
cations, and by analogy the enzymes that deposit and remove
the modiﬁcations are called ‘writers’ and ‘erasers’. Crucially, next
to covalent histone modiﬁcation, several sub-types of SNF2-type
ATP-dependent nucleosome remodelling enzymes are involved in
inserting and extracting histone H2A variants into existing nucleo-
somes [49–51], sliding nucleosomes along DNA [52–54], and in the
transfer of nucleosomes from one DNA segment to another [55].
Similar to histone code ‘writers’, some of the SNF2-family members
reside in large multi-subunit protein complexes that not only bind
nucleosomes to remodel them, but also harbour ‘reader’ domains
that target their activity to speciﬁcally modiﬁed nucleosomes.
A ﬁrst complicating aspect of the writer/reader system of his-
tone modiﬁcations is that ‘reader’ and ‘writer’ domains often
co-occur in the same protein complex. A second complicating
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spect is that the ‘histone writers’ also modify non-histone factors.
n fact, the lysine and arginine residues of writers and readers are
hemselves often subject to modiﬁcation [56–59].
Biochemically, writers such as methylases, acetylases, kinase,
biquitylases and other protein post-translational modiﬁcation
nzymes are antagonised by erasers such as demethylases, deacety-
ases, deubiquitylases, etc.  . ..  Furthermore, when one histone
ysine is the target of both acetylation and methylation, as is the
ase for histone H3 lysines 9 and 27 (H3K9 and H3K27), it will take
t least two enzymatic steps to move from the repressive methy-
ated state to the activating acetylated state (or vice versa) as these
ysine modiﬁcations are mutually exclusive. Thus, it is thought that
he status quo between opposing nucleosome-modifying activ-
ties is subject to alterations by sequence-speciﬁc DNA binding
ranscription factors that recruit speciﬁc chromatin modiﬁers and
emodellers to individual loci, tipping the balance towards more or
ess transcription [60].
.2. Chromatin colours
At this point it is relevant to indicate that much of the genome is
ranscribed at a low level in every cell population. This ﬁnding has
een replicated many times, most conclusively by next generation
equencing which demonstrated that indeed, most genes produce
RNAs, albeit at a low level. For instance, in monocytes and Mfs,
25% of the ∼20,000 protein coding genes are detectable at a very
ow level (>0.01 Reads Per Kilobase per Million sequence reads),
hile about 50% of protein coding genes achieve expression levels
n excess of 1 RPKM [61]. Hence the majority of transcription units
s potentially transcribed and it is therefore more a matter of how
ften transcription can take place rather than whether it takes place
t all. A black and white, open or closed, view of transcriptional
ontrol is not consistent with the body of evidence. In fact, multiple
colours’ of chromatin have been described [62,63].
An example of a self-sustaining and even amplifying ‘chromatin
olour’ was initially described for the constitutive heterochromatin
ark H3K9me3, which is associated with gene repression [41]. The
oncept is that the reader of this modiﬁcation can recruit the writer,
orming a positive feedback loop that allows spreading of the mark
long the length of the chromosome, as had been described in a
rocess called position effect variegation whereby DNA loci translo-
ated next to heterochromatin domains eventually are invaded by
he heterochromatin mark and therefore durably silenced [64]. A
ore recent study provided support for a similar self-sustaining
athway for facultative heterochromatin mark H3K27me3; the
2A ubiquitylation activity within the H2K27me3 PRC1 ‘reader’
omplex was shown to subsequently promotes H3K27me3 depo-
ition by the PRC2 ‘writer’ complex [65]. A third chromatin ‘colour’
s found at gene promoters, which are decorated with H3K4me3.
his modiﬁcation depends on H2BK120ubi1 which is itself erased
uring transcription elongation by the de-ubiquitylation module of
he SAGA H3/H2B acetyltransferase complex [66–70].
Hence, nucleosomal histones can carry modiﬁcations that
avour repression (H3K9me3, H3K27me3) or activation (H3K4me1,
3K4me3, acetylation) and these recruit ‘readers’ and ‘writers’ that
nduce a particular chromatin state at a given locus, participating
n cellular signal transduction towards the genome.
.3. Transcription initiation control
We  currently know that mRNA transcription initiation involves
istone modiﬁers, readers and remodelling complexes, gen-
ral transcription factors, and RNAPII interacting factors, which
ogether encompass more than 300 nuclear proteins [71]. Much
esearch indicates that transcription initiation sites are highly
eﬁned. Moreover, alternative initiation site usage for a gene Immunology 28 (2016) 359–367 361
often correlate with cell lineage and environmental stimuli [11].
Together with general RNA polymerase II transcription factors,
the chromatin remodelling enzymes coordinate nucleosome free-
regions and participate in the chromatin transactions that take
place as transcription initiation proceeds towards elongation. The
nucleosome-free regions at transcription start sites range from 70
to 500 bp in size and usually harbour ﬂanking +1 and a −1 nucleo-
somes that are decorated with the H2A variant H2AZ and harbour
H3K4me3 [72–74]. Notably, H3K4me3 can also be detected at active
enhancers [75,76] while H2AZ is found at most accessible DNA
regions of the genome [77].
In humans, CpG islands constitute ∼70% of all gene promoter
sites. CpG islands attract H3K4me3 deposition by binding to
CFP1, which is an integral subunit of H3K4 trimethylase com-
plexes [78–80]. On the other hand, H3K4me1, which decorates
most promoter-ﬂanking nucleosome arrays and many (potentially
active) enhancers, is the product of a second set of H3K4 methylase
complexes, namely MLL3 and MLL4 harbouring complexes [80–82].
Recent proﬁling of the genome-wide occupancy of eleven mouse
SNF2-type nucleosome remodelling enzymes in embryonic stem
cells indicates that not less than six of these localise to the nucle-
osome free regions of most transcription start sites that display
H3K4me3 on their ﬂanking nucleosomes, although in three cases
occupancy was not much correlated with actual gene expression
levels [74]. Ep400, which does correlate with transcription activ-
ity, modulates H2A-H2AZ variant substitution and is part of a very
large protein complex that also harbours the TIP60/KAT5 histone
H4/H2A acetyltransferase [83–86]. Chd4, whose occupancy does
not correlate directly with transcript levels, is a subunit of the NURD
complex that also contains a pair of histone deacetylases (HDAC1
and HDAC2) alongside multiple ancillary subunits [56,87–89]. It
remains to be determined in what sequence all these SNF2 ATPase
come into play at gene promoters.
The ENCODE project performed chromatin immuoprecipitation
of sequence-speciﬁc transcription factors and showed that they
constantly scan nucleosome free regions [90]. At nucleosome free
regions, activation and repression domains of the transcription
factors recruit or activate a diverse set of enzymes. Commonly
encountered targets are subunits of the evolutionarily conserved
multi-subunit general transcription factors called ‘the mediator’
and the P-TEFb elongation factor [91]. Like the TFIIH helicase
which is involved in RNAPII initiation, mediator and P-Tefb harbour
specialised cyclin–cyclin dependent kinase protein pairs whose
primary function is to phosphorylate the ∼50 C-terminal domain
heptapeptide repeats of the large subunit of RNAPII [92–97]. A
large body of literature indicates that transcription factors are able
to recruit histone modifying and remodelling activities [98,99].
Understanding the exact mechanisms by which transcription fac-
tors bound to promoters and enhancers stimulate transcription
remains an active ﬁeld of investigation [100,101].
3.4. Transcription control elements on chromosomes as sites of
molecular memory storage
To establish long-term memories in the brain, neurons need
to remodel their connections with other neurons. It has been
shown that this process requires transcription and relies on histone
methylases that deposit H3K4me3 at gene promoters [102–104].
Hence, also in the brain, epigenetic enzyme activity is key in
the storage of memories, presumably because nucleosome-based
transcription control enables ﬁxation of a transiently perceived
molecular signal via altered gene expression in the following
hours/days. More generally, it may  be that the complex and
highly coordinated set of protein–protein interactions that was ﬁrst
described to regulate gene expression potential in lower eukaryotes
[105–108] can result in some level of self-sustaining topological
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nd chemical bookmarking of the human genome’s promoters and
nhancers.
A straightforward class of models posits that in any cell type, a
tatus quo is attained at all genes in the genome. This status quo can
e biased towards transcription activation or towards repression,
epending on the local concentration of opposing activities that
ontrol rate-limiting steps in the process of transcription. Hence,
ell type-speciﬁc expression of histone ‘writer’ or ‘reader’ complex
ubunits may  well be an important key to cellular fate ﬁxation as
his would modulate the activity of subsets of sequence speciﬁc
NA binding transcription factors that are already present in the
ell but miss the presence of a particular chromatin remodelling
omplex (isoform) to inﬂuence gene expression [109–112].
Two memory-related questions can be asked at this point. How
o cells manage to hold on to their identity and avoid becoming
n unrelated cell type? A second question is how cells such as
acrophages remember environmental signals they perceived in
he past [113]? An emerging ﬁrst answer to both questions is that
he ∼1600 human TF genes (and the splice-isoforms they can give
ise to) together with the chromatin remodelling factors that write,
rase and read nucleosomal histone modiﬁcations are enough to
xplain the determination and differentiation of all the human cell
ypes [114–116]. However, since a cell not only consists of chro-
atin and transcription factors, much more comes into play to
aintain cell identity. Hence, RNA processing, transport and trans-
ation as well as non-transcription related interactions have the
otential to form stable regulatory networks that can help perpet-
ate a given memory. Secondly, cells are embedded in a predictable
nvironment consisting of other cells and tissue components, form-
ng a complex environment that they can sense and to which they
ontribute. Thirdly, temporal sequences of cellular events are likely
nbuilt in the epigenetic programs, so as to permit homeostasis in
he long term by providing a predictable physiological outcome
uch as tissue turnover or repair. Hence, once a choice is made,
 cells’ transcription factor network and its epigenetic program
ead down a predetermined path [31]. Elucidation of the programs
ssociated with the multitude of cell fates is a task for the present
imes.
. Macrophage epigenomes
Macrophages (Mfs) and related phagocytes exist in both pro-
erostome and deuterostome animals. In mammals, embryonically
etermined microglia in the brain, Kupfer cells in the liver and
issue-resident Mfs  and dendritic cells, as well as osteoclast in the
ones are examples of phagocytic cell types derived from the meso-
ermal lineage that performs haematopoiesis, the generation of
lood cells [117,118]. Haematopoiesis branches out to form many
ell types from one multipotent stem cell [119]. Our understanding
f haematopoiesis, and in particular the non-lymphoid lineages, has
rogressed greatly thanks to recent single cell transcriptome anal-
ses and mouse transplantation experiments, revealing a nested
ystem of decision-making processes [20,120–123]. Furthermore,
pigenomic characterisation revealed great plasticity in the epige-
etic programs of Mfs  that consist of >10,000 enhancers whose
ctivity changes when mouse Mfs  are transplanted from one organ
o another [124]. This is in keeping with the proposition that Mfs
re very receptive to their tissue environment [16,125–129].
For more than a decade we have known the signature of histone-
ncoded signals at gene promoters and enhancers [130,131].
urrently, within the international human epigenome consortium
IHEC) and associated projects such as the European BLUEPRINT
roject, puriﬁed cell populations from healthy donors are being
roﬁled for epigenetic marks along their chromosomes [132,133].
ddition of nuclease DNA accessibility data [134–136] alongside Immunology 28 (2016) 359–367
the nucleosome-borne information revealed that many acetylated
and methylated nucleosomes at promoters and enhancers are
adjacent to non-nucleosomal, highly accessible DNA stretches.
Altogether, this provides accurate epigenome maps. Epigenome
maps represent important information resources because they
reveal the genetic pathways that are active as well as those that
can be activated through further transcription factor binding [137].
Such anticipation of possible future events is the basis for a type of
cellular memory that is thought to be important for innate immune
memory and medicine because environmental signals, and the
resulting epigenomic marks, are potentially amenable to pharma-
cological intervention when innate immune system cells are too
active or not active enough [138].
Until recently, the powerful DNA rearrangement-mediated
memory features of lymphoid cells overshadowed the potential
for adaptive memory phenomena – that do not involve DNA rear-
rangements – in myeloid cells. During inﬂammation, monocytes
differentiate into macrophages (Mfs) in the absence of cell division.
Recent research underscores the capacity of adult monocytes not
only to adapt their behaviour upon exposure to microorganism-
associated molecular patterns (MAMPs) but also to consequently
give rise to Mfs  with different functionalities [139]. In fact, even
invertebrate organism Mfs  may  undergo developmental training
through engulfment of apoptotic embryonic cells, which appears
to empower subsequent infectious bacteria phagocytosis [140].
Besides autonomic and tissue patterned cell fate determination
mechanisms, innate immune cells such as Mfs  must tailor their
response to a potentially hostile environment that is a priori vari-
able if not unpredictable due to the plethora of commensal and
pathogenic microbes and viruses they may  encounter. To address
this issue, we  integrated the transcriptomes and the epigenomes
of three populations of Mfs  that were derived in vitro from healthy
adult human monocytes. The monocyte to Mf  differentiation condi-
tions consisted of 6 days of cultivation in 10% pooled human serum,
and differed only in the fact that the monocytes were exposed to
beta-glucan (BG), a fungal cell wall component, or to lipopolysac-
charide (LPS), a bacterial cell wall component, during the ﬁrst 24 h
of in vitro culture. The third populations served as unexposed con-
trol. At the sixth day of this protocol, Mfs  derived from BG-treated
monocytes are more pro-inﬂammatory and better phagocytes than
the control cells [139]. Hence they are said to be trained, a con-
cept with applications in vaccination [141]. On the other hand, Mfs
derived from monocytes treated with LPS secrete lower levels of
IL6 and TNF than the control Mfs. They are said to be tolerant, a
concept that has been linked to sepsis-induced immune paralysis
[138]. In both instances, the Mfs  studied on day 6 appear to ‘remem-
ber’ their precursor cell’s encounters with microbes during the ﬁrst
day of the experiment.
In total, 3.8 106 bp (0.12% of the human genome) undergo
nucleosome-borne epigenomic dynamics following exposure to
MAMPs  [61]. As output, 12% of the transcriptome was different
(4-fold change, p < 0.05) between the three Mf subtypes. There-
fore, a sizable proportion of the human chromatin and Mf  gene
expression program is affected upon detection of microorganisms.
Indeed, trained, control and tolerant Mfs  display transcriptomic
differences at all investigated levels, going from their interac-
tions potential with the extracellular matrix to signal receptors
and metabolite transporters at their plasma membrane, through
organelle and cytoplasm constituents and the signalling pathways
they harbour all the way  down to RNA processing and transcrip-
tion factor constellations, altogether resulting in the establishment
of reproducible Mf  fate trajectories.Training due to BG treatment induces H3K27 acetylation at more
than 3000 enhancer loci, generating a large exclusive signature.
The genes targeted by these enhancers are generally also active in
the other Mfs, however, indicating a positive modulating role on
ars in Immunology 28 (2016) 359–367 363
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Chromatin vocabulary box.
Transcription start site (TSS):  Site where DNA transcription
begins.
Transcription factor binding motif:  DNA sequence motif
recognized by proteins.
Histone modiﬁcation:  Nucleosome-bound molecular infor-
mation consists of histone amino acid post translational
modiﬁcations, of which more than 60 have been described to
date.
DNA Accessibility: Obtained through observed accessibility
to experimental probes. Is a region more likely to be bound by
TFs than by nucleosomes. Nucleosome depleted regions, a.k.a.
nucleosome free regions, occur at active TSSs and enhancers.
Promoter:  DNA sequence for productive transcription initia-
tion. The coordinates for a promoter must encompass at least
one TSS, but extend to encompass adjoining DNA sequence
and nucleosome-encoded molecular information.
Enhancer:  Operational sequence that encompasses DNA- and
nucleosome-borne information and which is capable of inﬂu-
encing juxtaposed promoter activity. Enhancers are devoid of
functional TSS for mRNAs, although enhancers may  be tran-
scribed [154].
Differentially modiﬁed DNA: Deﬁned by the extent of
cytosine or other nucleobase post-replicational covalent mod-
iﬁcation.
Loops to:  topological notation for binary or higher order inter-
action between deﬁned DNA elements.
Topologically associated domains (TADs): All the DNA
located within a TAD is more likely to interact with other DNA
sequences within the same TAD than with DNA located outside
this TAD.
Boundary: DNA sequence that delimits one side of a TAD.C. Logie, H.G. Stunnenberg / Semin
ene expression and rarely all or nothing gene activation events.
ikewise, LPS-induced nucleosome acetylation increases at some
00 loci. For the endotoxin tolerant Mfs  obtained by pre-treatment
f the monocyte precursor cells with LPS, these changes often
nvolve sustained expression of genes that were already active in
onocytes, but now through newly established enhancers that are
nique to the tolerant Mfs  [61].
Besides H3K27 acetylation, which reports both enhancer and
romoter activity, H3K4me3 marks >20,000 promoter loci, deco-
ating the promoters of all the genes whose expression is detected
t the RNA level in the monocyte-derived Mfs. Contrary to the sharp
3K4me3 peaks encompassing less than 3 nucleosomes (median
50 bp), H3K4me1, a precursor of the promoter H3K4me3 mark,
s distributed over larger regions (median 3.5 kb). Interestingly,
3K4me1 marking, persists long after H3K27ac signals dimin-
shed [61]. As suggested for by Gioacchino Natoli [142], H3K4me1
mbodies mid- to long-term epigenetic activity, perhaps by facil-
tating ulterior (re)activation of a transcription start site or an
nhancer, a state referred to as latency. Nevertheless, this mark
an be transient [15].
Are there key orchestrators of the Mf  epigenome? Yes, in
otal more than 200 TFs, 100 kinases and 20 epigenetic enzymes
ere differentially expressed after monocyte to Mf  differentia-
ion [61]. For instance, the KDM6B/JMJD3 lysine de-methylase is
ather uniquely expressed in monocytes and the E-box binding
2H2 zinc ﬁnger TF SNAI1 of monocytes is largely replaced by
ts SNAI3 paralog in Mfs. The NFKB regulator IRAK3 is epigeneti-
ally and transcriptionally upregulated in endotoxin paralysed Mfs,
nd G-coupled receptors, such as the Adora receptors, and many
AMP signal transduction factors are expressed differentially by
G trained Mfs  relative to control and paralyzed Mfs  [61]. Fur-
hermore, the trained cell’s metabolism is remodelled; including
ncreased glycolytic capacity, cytoplasmic malate and isocitrate
ehydrogenases and cholesterol metabolizing enzymes [61,143].
hese and other metabolic changes are themselves likely to impact
he dynamics of chromatin modiﬁcations through altered availabil-
ty of co-factors for the writers and erasers of histone modiﬁcations
82,144–146].
. Conclusions and perspective
We  have known the ∼20,000 human protein coding genes for
ore than 15 years, but are just now starting to discover all the
egulatory DNA sequences that make up enhancers and promoters
hat control their expression. It is well established that enhancer
nd promoter usage is a deﬁning property of cell lineages and
ub-types [147]. Hence, comprehensive functional annotation of
he epigenomically active loci will greatly impact diagnostic and
rognostic tool development because novel fundamental knowl-
dge about the inner workings of human cells will undoubtedly
e revealed [148]. Within cellular chromatin, we can use generic
echnologies to systematically map  accessible regions [136,149],
ucleosome-borne epigenetic signals [130,150], post-replicational
-cytosine methylation [151,152] as well as looping interactions
etween enhancers and promoters [17]. Developing these new
olecular biology resources through annotation in well-curated
atabases will extend our knowledge considerably. This can then be
ntegrated with the human TF repertoire recognition motifs [153],
nd with knowledge on the chromatin remodelling enzymes that
re recruited by TFs, to provide models of molecular signal trans-
uction pathways where the DNA elements have importance on
ar with that of proteins. Very recently, a European COST action
as been awarded to push these issues forward in a globally coor-
inated open context (www.cost.eu/COST Actions/ca/CA15205).Legend: Although the protein-DNA interactions that guide gene
expression are extraordinarily intricate, when viewed from a DNA
point of view, the number of possible transactions is small. The
transactions involve distinct cis-acting DNA elements (promoters,
enhancers, boundaries) that engage in higher order loops that are
controlled by DNA-bound proteins. Operationally, a silencer may
be a negatively acting enhancer, but it may  also be a conditional
boundary that can interrupt the looping interaction between a pro-
moter and an enhancer. Similarly, decommissioning of a boundary
may  lead to gene activation, as this would permit novel promoter-
enhancer loops to be formed [100].
Finally, an important corollary of epigenome proﬁling is that
once DNA loci that function in regulation of speciﬁc cell behaviour
have been catalogued (See vocabulary box), the genetic variation
in these regions within the human population can be investigated
too [149]. Since the majority of human variation resides outside
the protein coding DNA we  may  then start to understand human
biology much more deeply than we  currently do.
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